Pricing Log in Create free account

Adlai Nortye Ltd. Sponsored ADR (ANL) vs Iambic Therapeutics, Inc. (IAM)

Adlai Nortye Ltd. Sponsored ADR and Iambic Therapeutics, Inc. are both Biotechnology companies. Adlai Nortye Ltd. Sponsored ADR and Iambic Therapeutics, Inc. are of similar size ($568.5M and $551.7M).

Valuation

Metric ANL IAM Biotechnology median
P/E — — 10.60
P/S — — 9.40
P/B n/m — 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m — 0.66
EV/Sales n/m — 9.02
Earnings yield — — (32.88%)
Free cash flow yield 0.00% — (23.13%)

Profitability

Metric ANL IAM Biotechnology median
Gross margin — — 68.51%
Operating margin — — 0.00%
Net margin — — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity 0.00% — (51.96%)
Return on assets 0.00% — (46.06%)
Return on invested capital 0.00% — 0.00%

Growth

Metric ANL IAM Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 31.48% — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ANL IAM Biotechnology median
Debt to equity 0.12 — 0.00
Current ratio 9.55 — 4.97
Net debt to EBITDA (0.05) — 1.01

Dividend

Metric ANL IAM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANL IAM Biotechnology median
Market cap 568.51m 551.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack